ALN-HTT02 clinical trials

A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease

This study is testing a new medicine, ALN-HTT02, for Huntington's disease. Researchers want to see if it's safe and how it works in the body. It's a first-step study, comparing the new medicine to a dummy treatment (placebo) in adults aged 25-70.